BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37934100)

  • 21. Targetoid Primary Liver Malignancy in Chronic Liver Disease: Prediction of Postoperative Survival Using Preoperative MRI Findings and Clinical Factors.
    Park SH; Heo S; Kim B; Lee J; Choi HJ; Sung PS; Choi JI
    Korean J Radiol; 2023 Mar; 24(3):190-203. PubMed ID: 36788766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI-Based Radiomics: Associations With the Recurrence-Free Survival of Patients With Hepatocellular Carcinoma Treated With Conventional Transcatheter Arterial Chemoembolization.
    Song W; Yu X; Guo D; Liu H; Tang Z; Liu X; Zhou J; Zhang H; Liu Y; Liu X
    J Magn Reson Imaging; 2020 Aug; 52(2):461-473. PubMed ID: 31675174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
    Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
    Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
    Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
    Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters.
    Wang L; Feng B; Li D; Liang M; Wang S; Wang S; Ma X; Zhao X
    Eur Radiol; 2023 May; 33(5):3592-3603. PubMed ID: 36884087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor volume measured using MR volumetry as a predictor of prognosis after surgical resection of single hepatocellular carcinoma.
    Jeon SK; Lee DH; Park J; Suh KS; Yi NJ; Hong SK; Han JK
    Eur J Radiol; 2021 Nov; 144():109962. PubMed ID: 34562746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
    Rong D; Liu W; Kuang S; Xie S; Chen Z; Chen F; Xie Q; Luo Q; He B; Zhang Y; Deng Y; Yang H; Chen S; Wang J
    Eur Radiol; 2021 Oct; 31(10):7584-7593. PubMed ID: 33860826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the seventh American Joint Committee on Cancer System.
    An C; Choi GH; Lee HS; Kim MJ
    Invest Radiol; 2012 Nov; 47(11):634-41. PubMed ID: 22814590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Kitao A; Matsui O; Zhang Y; Ogi T; Nakada S; Sato Y; Harada K; Yoneda N; Kozaka K; Inoue D; Yoshida K; Koda W; Yamashita T; Yamashita T; Kaneko S; Kobayashi S; Gabata T
    Radiology; 2023 Feb; 306(2):e220531. PubMed ID: 36219111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.
    Hwang JA; Lee S; Lee JE; Yoon J; Choi SY; Shin J
    J Magn Reson Imaging; 2023 Mar; 57(3):930-938. PubMed ID: 35833798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection.
    Wang JC; Hou JY; Chen JC; Xiang CL; Mao XH; Yang B; Li Q; Liu QB; Chen J; Ye ZW; Peng W; Sun XQ; Chen MS; Zhou QF; Zhang YJ
    Eur J Cancer; 2021 Sep; 155():85-96. PubMed ID: 34371445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application value of machine learning algorithms for predicting recurrence after resection of early-stage hepatocellular carcinoma].
    Ji GW; Wang K; Xia YX; Li XC; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):679-685. PubMed ID: 34192861
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Joo I; Kim SY; Kang TW; Kim YK; Park BJ; Lee YJ; Choi JI; Lee CH; Park HS; Lee K; Kim H; Yu E; Kang HJ; Ha SY; Kim JY; Ahn S; Jung ES; Kim BH; Han HS; Lee JM
    Radiology; 2020 Aug; 296(2):335-345. PubMed ID: 32484414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Wei H; Jiang H; Qin Y; Wu Y; Lee JM; Yuan F; Zheng T; Duan T; Zhang Z; Qu Y; Chen J; Chen Y; Ye Z; Yao S; Zhang L; Yang T; Song B
    Eur Radiol; 2022 Nov; 32(11):7578-7589. PubMed ID: 35554652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvascular invasion-negative hepatocellular carcinoma: Prognostic value of qualitative and quantitative Gd-EOB-DTPA MRI analysis.
    Wang L; Liang M; Feng B; Li D; Cong R; Chen Z; Wang S; Ma X; Zhao X
    Eur J Radiol; 2023 Nov; 168():111146. PubMed ID: 37832198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-operative ADC predicts early recurrence of HCC after curative resection.
    Lee S; Kim SH; Hwang JA; Lee JE; Ha SY
    Eur Radiol; 2019 Feb; 29(2):1003-1012. PubMed ID: 30027408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
    Cha DI; Jang KM; Kim SH; Kim YK; Kim H; Ahn SH
    Korean J Radiol; 2020 Apr; 21(4):402-412. PubMed ID: 32193888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.